References
- KurreckJRNA interference: from basic research to therapeutic applicationsAngew Chem Int Ed Engl20094881378139819153977
- FireAXuSMontgomeryMKKostasSADriverSEMelloCCPotent and specific genetic interference by double-stranded RNA in Caenorhabditis elegansNature199839166698068119486653
- ElbashirSMHarborthJLendeckelWYalcinAWeberKTuschlTDuplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cellsNature2001411683649449811373684
- ZimmermannTSLeeACAkincARNAi-mediated gene silencing in non-human primatesNature2006441708911111416565705
- DavisMEZuckermanJEChoiCHEvidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesNature201046472911067107020305636
- AkincAZumbuehlAGoldbergMA combinatorial library of lipid-like materials for delivery of RNAi therapeuticsNat Biotechnol200826556156918438401
- LoveKTMahonKPLevinsCGLipid-like materials for low-dose, in vivo gene silencingProc Natl Acad Sci U S A201010751864186920080679
- WangXLRamusovicSNguyenTLuZRNovel polymerizable surfactants with pH-sensitive amphiphilicity and cell membrane disruption for efficient siRNA deliveryBioconjug Chem20071862169217717939730
- WangXLXuRLuZRA peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA deliveryJ Control Release2009134320721319135104
- WangXLXuRWuXGillespieDJensenRLuZRTargeted systemic delivery of a therapeutic siRNA with a multifunctional carrier controls tumor proliferation in miceMol Pharm20096373874619296675
- OwensDE3rdPeppasNAOpsonization, biodistribution, and pharmacokinetics of polymeric nanoparticlesInt J Pharm200630719310216303268
- LiSDHuangLPharmacokinetics and biodistribution of nanoparticlesMol Pharm20085449650418611037
- FurumotoKYokoeJOgawaraKEffect of coupling of albumin onto surface of PEG liposome on its in vivo dispositionInt J Pharm20073291–211011617000067
- YokoeJSakuragiSYamamotoKAlbumin-conjugated PEG liposome enhances tumor distribution of liposomal doxorubicin in ratsInt J Pharm20083531–2283418082345
- KratzFAlbumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticlesJ Control Release2008132317118318582981
- XuRFisherMJulianoRLTargeted albumin-based nanoparticles for delivery of amphipathic drugsBioconjug Chem201122587087821452893
- LowKWackerMWagnerSLangerKvon BriesenHTargeted human serum albumin nanoparticles for specific uptake in EGFR-Expressing colon carcinoma cellsNanomedicine20117445446321215330
- SebakSMirzaeiMMalhotraMKulamarvaAPrakashSHuman serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysisInt J Nanomedicine2010552553220957217
- KumarCSSRBiological and Pharmaceutical Nanomaterials1st edWeinheim, GermanyWiley-VCH2006
- FoleyJONelsonKEMashadi-HosseinAFinlaysonBAYagerPConcentration gradient immunoassay. 2. Computational modeling for analysis and optimizationAnal Chem200779103549355317437333
- MacDonaldDEMarkovicBAllenMSomasundaranPBoskeyALSurface analysis of human plasma fibronectin adsorbed to commercially pure titanium materialsJ Biomed Mater Res19984111201309641632